AIM
DXCM icon

Advantage Investment Management’s DexCom DXCM Stock Holding History

Advantage Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-204
Closed -$4K – 865
2015
Q3 		$4K Buy
+204
New +$4.55K ﹤0.01% 678

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Advantage Investment Management's DXCM Position: Q4 2015 in Review

Advantage Investment Management sold out of DexCom (DXCM) in Q4 2015, closing a stake of 204 shares — an estimated $4K sold.

Advantage Investment Management first reported a position in DXCM in Q3 2015 and held it in 1 quarter. The position peaked at $4K in Q3 2015. 287 funds tracked by Wall St. Rank hold DXCM as of Q4 2015.

  • Advantage Investment Management reported no remaining DexCom position as of Q4 2015 after selling out during the quarter.
  • Advantage Investment Management sold 204 DexCom shares in Q4 2015, an estimated $4K.
  • Advantage Investment Management first reported a position in DexCom in Q3 2015 and held it in 1 quarter.
  • Advantage Investment Management's DexCom position peaked at $4K in Q3 2015.
  • 287 funds tracked by Wall St. Rank held DexCom as of Q4 2015.

Based on Advantage Investment Management's 13F filing for Q4 2015, filed 27 Mar 2017.